Delivery Order SPE2DB22D2007-SPE2DB25FJ3YF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price ceiling value of $5,752.28. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive delivery order, which carries no set-aside designation, represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a ceiling value of $19,515.80. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) under a firm fixed-price contract valued at $51,984.29. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract award was not set aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count) with a ceiling value of $2,133.12. This competitive contract, awarded on August 20, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.12 to AmerisourceBergen Drug Corp for Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,199.22. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for ultimate completion by July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3YFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,953.56 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count). The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is scheduled for completion by August 15, 2025, with an award date of August 14, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. As a prime contractor supporting DLA's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide. The company's demonstrated capability to fulfill such federal medical procurement requirements through open competition, combined with its expansive IDC, positions it as a critical vendor for delivering essential medications across multiple therapeutic domains to defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/14/25 |